4.7 Review

Potential New Therapies for Pediatric Diffuse Intrinsic Pontine Glioma

Journal

FRONTIERS IN PHARMACOLOGY
Volume 8, Issue -, Pages -

Publisher

FRONTIERS MEDIA SA
DOI: 10.3389/fphar.2017.00495

Keywords

DIPG; H3K27M; epigenetic therapy; immunotherapy; stem cells; nanoparticles

Funding

  1. National Natural Science Foundation of China [81572766]
  2. Guangdong Innovative and Entepreneurial Research Team Program [2016ZT06S029]
  3. SYSU Young Teachers Training Program [16YKZD14]

Ask authors/readers for more resources

Diffuse intrinsic pontine glioma (DIPG) is an extensively invasive malignancy with infiltration into other regions of the brainstem. Although large numbers of specific targeted therapies have been tested, no significant progress has been made in treating these high-grade gliomas. Therefore, the identification of new therapeutic approaches is of great importance for the development of more effective treatments. This article reviews the conventional therapies and new potential therapeutic approaches for DIPG, including epigenetic therapy, immunotherapy, and the combination of stem cells with nanoparticle delivery systems.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available